Episode 36
Better Health, Brighter Future for Rare with Dan Curran
Patient Empowerment Program: A Rare Disease Podcast
October 4, 202329m 52s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Daniel Curran leads Takeda’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community in an effort to produce treatments that result in better health and a brighter future for rare.
- 2:02 How rare disease is defined at Takeda
- 4:10 Rare disease units at Takeda
- 5:23 How Takeda economically justifies half of their pipeline being rare disease drugs
- 9:06 The price of rare disease drugs is too high
- 12:15 Why rare disease efforts are often associated with hematology
- 14:57 What Dr. Curran enjoys about leading Takeda's rare genetics and hematology therapeutic unit
- 16:42 Dr. Curran's professional journey
- 20:50 Takeda's choice to support n-Lorem